{ "meta": { "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.", "terms": "https://open.fda.gov/terms/", "license": "https://open.fda.gov/license/", "last_updated": "2026-09-09", "results": { "skip": 0, "limit": 1, "total": 1 } }, "results": [ { "codes": [ { "uuid": "7021cedc-942f-41af-98c6-63e8fe41ba7f", "code": "U87RX375T5", "type": "PRIMARY", "code_system": "FDA UNII" } ], "substance_class": "protein", "references": [ { "uuid": "c56488f3-afe9-4ae6-8cc7-c64642b5ff4d", "citation": "https://go.drugbank.com/drugs/DB06709", "url": "https://go.drugbank.com/drugs/DB06709", "doc_type": "DRUG BANK", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "78802d03-ca85-4eff-8aa4-99d1d06dc546", "citation": "http://www.uniprot.org/uniprot/P08172", "url": "http://www.uniprot.org/uniprot/P08172", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "b23c0f7c-d9cb-418b-b324-035d7b986c79", "citation": "UNIPROT", "doc_type": "UNIPROT", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "818010ef-b637-4f4c-83ad-868891abf16f", "citation": "Aura, Juhana, Jouni Sirviö, and Paavo Riekkinen Jr. \"Methoctramine moderately improves memory but pirenzepine disrupts performance in delayed non-matching to position test.\" European journal of pharmacology 333.2-3 (1997): 129-134.", "url": "https://www.sciencedirect.com/science/article/pii/S0014299997011345", "doc_type": "JA", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "7c4bfc5b-0551-4c1a-a4d4-1cf7761a30e8", "citation": "https://drugs.ncats.io/drug/1IAT42T80T", "url": "https://drugs.ncats.io/drug/1IAT42T80T", "doc_type": "WEBSITE", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "f430aa16-5ead-4492-a2d7-8e2e6fe4a163", "citation": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2018/210598Orig1s000PharmR.pdf", "doc_type": "NDA PUBLIC REVIEW", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "bfbd546c-4a7c-415d-8651-7add0eeb82ec", "citation": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2018/210598Orig1s000PharmR.pdf", "doc_type": "NDA PUBLIC REVIEW", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "d312216c-1033-404c-b244-72b1ad402190", "citation": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210598s000lbl.pdf", "doc_type": "NDA PUBLIC REVIEW", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "2f9a66df-6599-4f72-8510-580a5e236f78", "citation": "Ikeda, Ken, et al. \"M 3 receptor antagonism by the novel antimuscarinic agent solifenacin in the urinary bladder and salivary gland.\" Naunyn-Schmiedeberg's archives of pharmacology 366.2 (2002): 97-103.", "url": "Ikeda, Ken, et al. \"M 3 receptor antagonism by the novel antimuscarinic agent solifenacin in the urinary bladder and salivary gland.\" Naunyn-Schmiedeberg's archives of pharmacology 366.2 (2002): 97-103.", "doc_type": "JA", "public_domain": true }, { "uuid": "b3d374bc-19f8-479d-9a90-52f620afb248", "citation": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2012/202450Orig1s000PharmR.pdf", "doc_type": "NDA PUBLIC REVIEW", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "1c2b821e-456a-4fad-a955-56b85244b860", "citation": "Haddad, El‐Bdaoui, et al. \"Pharmacological characterization of the muscarinic receptor antagonist, glycopyrrolate, in human and guinea‐pig airways.\" British journal of pharmacology 127.2 (1999): 413-420.", "url": "https://bpspubs.onlinelibrary.wiley.com/doi/epdf/10.1038/sj.bjp.0702573", "doc_type": "JA", "public_domain": true }, { "uuid": "9f14f4f4-585f-424b-9016-62683e8613fb", "citation": "Corena-McLeod, Maria. \"Comparative pharmacology of risperidone and paliperidone.\" Drugs in R&D 15.2 (2015): 163-174.", "url": "https://link.springer.com/article/10.1007/s40268-015-0092-x", "doc_type": "JA", "public_domain": true }, { "uuid": "65c76619-ef26-4b2c-bc81-02377fbacb2c", "citation": "Corena-McLeod, Maria. \"Comparative pharmacology of risperidone and paliperidone.\" Drugs in R&D 15.2 (2015): 163-174.", "url": "https://link.springer.com/article/10.1007/s40268-015-0092-x", "doc_type": "JA", "public_domain": true }, { "uuid": "6ba4e222-f6ce-48bb-946e-6e7535c42d00", "citation": "https://en.wikipedia.org/wiki/Oxybutynin", "doc_type": "WIKI", "public_domain": true }, { "uuid": "462d31eb-7ff3-4d41-8a3e-cffbdd327dc4", "citation": "https://www.drugbank.ca/drugs/DB00572", "doc_type": "WEBSITE", "public_domain": true }, { "uuid": "41dc9bb0-04a1-4052-85e3-e122ab574e57", "citation": "WO2018050510 (Scifinder ref)", "doc_type": "PATENT", "public_domain": true }, { "uuid": "e6e2a6f7-6bf6-490a-b680-bd62c57b1f01", "citation": "Corena-McLeod, Maria. \"Comparative pharmacology of risperidone and paliperidone.\" Drugs in R&D 15.2 (2015): 163-174.", "url": "https://link.springer.com/article/10.1007/s40268-015-0092-x", "doc_type": "JA", "public_domain": true }, { "uuid": "dc6ae97f-73cf-4a58-ada8-1573f925ab5f", "citation": "https://www.eurofinsdiscovery.com/catalogmanagement/viewItem/93", "url": "https://www.eurofinsdiscovery.com/catalogmanagement/viewItem/93", "doc_type": "ASSAY REFERENCE", "public_domain": true }, { "uuid": "01fdec83-2785-479e-86b7-e714da293922", "citation": "https://www.eurofinsdiscovery.com/catalogmanagement/viewItem/93", "url": "https://www.eurofinsdiscovery.com/catalogmanagement/viewItem/93", "doc_type": "ASSAY REFERENCE", "public_domain": true }, { "uuid": "128bb5b4-2e26-490c-8642-bd3c0234a1ce", "citation": "https://www.sciencedirect.com/science/article/pii/S0304395901003190", "url": "https://www.sciencedirect.com/science/article/pii/S0304395901003190", "doc_type": "JA", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "a77fe0a0-f55f-4fe1-8f1c-a254a6934041", "citation": "https://www.eurofinsdiscovery.com/catalogmanagement/viewItem/93", "url": "https://www.eurofinsdiscovery.com/catalogmanagement/viewItem/93", "doc_type": "ASSAY REFERENCE", "public_domain": true }, { "uuid": "747f3aed-b004-4b32-b209-34bb8768c98e", "citation": "https://drugs.ncats.io/substance/4XFD7B36M6", "url": "https://drugs.ncats.io/substance/4XFD7B36M6", "doc_type": "WEBSITE", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "acb7d578-a157-40ca-a3ea-ed89440b15e0", "citation": "https://www.alzforum.org/therapeutics/milameline", "url": "https://www.alzforum.org/therapeutics/milameline", "doc_type": "WEBSITE", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "e5a27eb9-9a2c-43f4-a671-b8224ff90f97", "citation": "Miller, J_ H., V. A. Gibson, and M. McKinney. \"Binding of [3H] AF-DX 384 to cloned and native muscarinic receptors.\" Journal of Pharmacology and Experimental Therapeutics 259.2 (1991): 601-607.", "url": "https://jpet.aspetjournals.org/content/jpet/259/2/601.full.pdf", "doc_type": "JA", "public_domain": true }, { "uuid": "6e335277-5e11-4126-8ba2-bb76325efce6", "citation": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4827886/pdf/ceg-9-083.pdf", "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4827886/pdf/ceg-9-083.pdf", "doc_type": "JA", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "fe9a83c2-c91b-485e-af5f-d80a7c6491ff", "citation": "https://www.eurofinsdiscovery.com/catalogmanagement/viewItem/93", "url": "https://www.eurofinsdiscovery.com/catalogmanagement/viewItem/93", "doc_type": "ASSAY REFERENCE", "public_domain": true }, { "uuid": "5759d28b-934a-4354-a473-2e539042aed5", "citation": "https://www.drugbank.ca/drugs/DB00572", "doc_type": "WEBSITE", "public_domain": true }, { "uuid": "85e5c1b9-e722-41de-8f19-1b8635d85712", "citation": "https://www.eurofinsdiscovery.com/catalogmanagement/viewItem/93", "url": "https://www.eurofinsdiscovery.com/catalogmanagement/viewItem/93", "doc_type": "ASSAY REFERENCE", "public_domain": true }, { "uuid": "561bd1d1-ba49-4fa7-9a9b-9b75e33aedf5", "citation": "MICAD Research Team. \"Molecular Imaging and Contrast Agent Database (MICAD)[Internet].\" National Center for Biotechnology Information (US) (2007).t", "url": "https://www.ncbi.nlm.nih.gov/books/NBK23717/", "doc_type": "BOOK", "public_domain": true }, { "uuid": "797bdfd8-76d6-4764-be48-df6df6411d1b", "citation": "https://www.eurofinsdiscovery.com/catalogmanagement/viewItem/93", "url": "https://www.eurofinsdiscovery.com/catalogmanagement/viewItem/93", "doc_type": "ASSAY REFERENCE", "public_domain": true }, { "uuid": "0f6a3922-8b1f-4c7d-9448-95b348ec465a", "citation": "Singh A. Xanomeline and Trospium: A Potential Fixed Drug Combination (FDC) for Schizophrenia-A Brief Review of Current Data. Innov Clin Neurosci. 2022 Oct-Dec;19(10-12):43-47. PMID: 36591549; PMCID: PMC9776782.", "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9776782/", "doc_type": "JA", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "8976942e-e03e-4294-ae47-3a7eb8e968fa", "citation": "MICAD Research Team. \"Molecular Imaging and Contrast Agent Database (MICAD)[Internet].\" National Center for Biotechnology Information (US) (2007).t", "url": "https://www.ncbi.nlm.nih.gov/books/NBK23717/", "doc_type": "BOOK", "public_domain": true }, { "uuid": "6ee65c81-0846-4f24-95b5-bea04a76263c", "citation": "Lee, Min Jung, et al. \"Pharmacological characterization of DA-8010, a novel muscarinic receptor antagonist selective for urinary bladder over salivary gland.\" European Journal of Pharmacology 843 (2019): 240-250.", "url": "https://www.sciencedirect.com/science/article/pii/S0014299918306915", "doc_type": "JA", "public_domain": true }, { "uuid": "0a395874-c1e6-43f0-89b9-7330b36bf148", "citation": "https://www.sciencedirect.com/topics/pharmacology-toxicology-and-pharmaceutical-science/talsaclidine", "url": "https://www.sciencedirect.com/topics/pharmacology-toxicology-and-pharmaceutical-science/talsaclidine", "doc_type": "WEBSITE", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] } ], "definition_type": "PRIMARY", "definition_level": "COMPLETE", "uuid": "2eec7d35-d4a8-421d-97b7-1ae93c229b25", "version": "53", "unii": "U87RX375T5", "relationships": [ { "uuid": "cfb607b2-9a30-4323-b4ce-d2498ac62683", "amount": { "uuid": "398ebebd-749f-45b5-8f37-329049c88626" }, "type": "INHIBITOR->TARGET", "related_substance": { "uuid": "673b676c-25bf-414f-bc30-443aa0b39042", "refuuid": "e088275a-a45c-4dfe-b41f-f49921f9c672", "name": "DOXEPIN", "unii": "5ASJ6HUZ7D", "linking_id": "5ASJ6HUZ7D", "ref_pname": "DOXEPIN" } }, { "uuid": "85bd7062-e08a-4d1c-96e2-2a953331c619", "amount": { "uuid": "4a797d21-928d-422a-aed2-3203266acb1f" }, "type": "AGONIST->TARGET", "related_substance": { "uuid": "7ea69b60-f081-4eda-be11-f3bb5247693b", "refuuid": "7558b8b2-b775-4fca-a6d6-8bb2b3beed4b", "name": "CARBACHOL", "unii": "8Y164V895Y", "linking_id": "8Y164V895Y", "ref_pname": "CARBACHOL" } }, { "uuid": "51c9e27c-9679-48d8-b5cb-76453d8e4459", "amount": { "uuid": "41fafb02-441e-4664-a61f-146ab5ab5bf7", "average": 0.61, "units": "NANOMOLAR" }, "qualification": "Kd", "type": "INHIBITOR->TARGET", "interaction_type": "BINDING", "references": [ "bfbd546c-4a7c-415d-8651-7add0eeb82ec", "d312216c-1033-404c-b244-72b1ad402190" ], "related_substance": { "uuid": "4f84e202-4395-41c3-9559-a51778eb1bcd", "refuuid": "9ba5a86e-eb06-4d83-bf8a-64279e729438", "name": "REVEFENACIN", "unii": "G2AE2VE07O", "linking_id": "G2AE2VE07O", "ref_pname": "REVEFENACIN" } }, { "uuid": "f425d950-12f2-42a1-a7dd-92cbb5748c15", "amount": { "uuid": "a03b1abe-5afa-49f8-ab70-ee707d172fb3", "average": 2.1, "units": "NANOMOLAR" }, "comments": "THRX-195518 possesses activity at target muscarinic receptors that was slightly lower (approximately one-third to one-tenth) than revefenacin.", "qualification": "Ki", "type": "INHIBITOR->TARGET", "interaction_type": "BINDING", "references": [ "f430aa16-5ead-4492-a2d7-8e2e6fe4a163" ], "related_substance": { "uuid": "79c10636-c635-497e-a330-49cfccae4fbf", "refuuid": "a572ad37-1bc2-48a4-a9b0-1b63da9126cc", "name": "THRX-195518", "unii": "A6X64T4LZ4", "linking_id": "A6X64T4LZ4", "ref_pname": "THRX-195518" } }, { "uuid": "7941d569-bc91-46c3-ad2c-c5f982884d30", "type": "AGONIST->TARGET", "related_substance": { "uuid": "4d1ecd91-7ae4-475f-ba16-1b9477e85c7c", "refuuid": "3ccc705e-3337-4708-b6de-7541644a3560", "name": "Pilocarpine", "unii": "01MI4Q9DI3", "linking_id": "01MI4Q9DI3", "ref_pname": "Pilocarpine" } }, { "uuid": "7fb9ae4d-c968-434d-867d-48b940168102", "amount": { "uuid": "53b4ee2b-f657-4d91-912c-d6eec8b73b3d" }, "type": "INHIBITOR->TARGET", "references": [ "6ba4e222-f6ce-48bb-946e-6e7535c42d00" ], "related_substance": { "uuid": "0bef2354-71f9-4ec5-972f-899919f1cd9e", "refuuid": "c4aff9b4-8183-43d0-a5db-65b928d53d20", "name": "Aroxybutynin", "unii": "5BRQ29UUB7", "linking_id": "5BRQ29UUB7", "ref_pname": "Aroxybutynin" } }, { "uuid": "38484948-b1ef-493e-94f3-33ccbb2c53dc", "amount": { "uuid": "a0780050-5966-46a3-9246-ebb0c8979914", "average": 1.5, "units": "NANOMOLAR" }, "qualification": "IC50", "type": "INHIBITOR->TARGET", "references": [ "5759d28b-934a-4354-a473-2e539042aed5", "85e5c1b9-e722-41de-8f19-1b8635d85712" ], "related_substance": { "uuid": "f03f6f62-a7e3-4085-a6e9-335b25b19f24", "refuuid": "bd1911ab-5462-408a-b78c-77083b8ba70c", "name": "ATROPINE", "unii": "7C0697DR9I", "linking_id": "7C0697DR9I", "ref_pname": "ATROPINE" } }, { "uuid": "430d44f9-0259-491c-9364-96b05ab9f119", "type": "INHIBITOR->TARGET", "related_substance": { "uuid": "7916299d-5ad9-4099-a07a-c0161e3225c0", "refuuid": "7e98a4ac-ad66-4a61-9c18-bfff3fca17af", "name": "ROCURONIUM", "unii": "WRE554RFEZ", "linking_id": "WRE554RFEZ", "ref_pname": "ROCURONIUM" } }, { "uuid": "8c00ca0c-77b5-42d9-80a5-a63d582832a2", "amount": { "uuid": "56a4c6d2-dbea-4a1f-9ab4-7dc3806685cd", "average": 61, "units": "%" }, "type": "INHIBITOR->OFF-TARGET", "related_substance": { "uuid": "0dee4f88-210f-442a-869c-6d5bb54a603e", "refuuid": "9fc83886-7ba4-424d-9b87-debc23fa9ad6", "name": "NERATINIB", "unii": "JJH94R3PWB", "linking_id": "JJH94R3PWB", "ref_pname": "NERATINIB" } }, { "uuid": "450c5cbe-714a-4b3b-8c00-ac15c71a483d", "amount": { "uuid": "7f5c4ed2-b33c-4cb1-a707-6a80a8fbdb13", "average": 61, "units": "%" }, "type": "INHIBITOR->TARGET", "related_substance": { "uuid": "fe4faa8a-4407-4f0f-a8ad-609ffe27d495", "refuuid": "9fc83886-7ba4-424d-9b87-debc23fa9ad6", "name": "NERATINIB", "unii": "JJH94R3PWB", "linking_id": "JJH94R3PWB", "ref_pname": "NERATINIB" } }, { "uuid": "1ed5b0c5-4a93-42db-9b80-d8f2e92c11c5", "type": "INHIBITOR->TARGET", "related_substance": { "uuid": "37523dde-d95a-451f-9548-533c51500e31", "refuuid": "ee2f2936-d51a-495b-96e0-b3fef32ae001", "name": "TOLTERODINE", "unii": "WHE7A56U7K", "linking_id": "WHE7A56U7K", "ref_pname": "TOLTERODINE" } }, { "uuid": "064961b6-26c9-438b-880b-ed944a20fc26", "type": "INHIBITOR->TARGET", "related_substance": { "uuid": "1c066b87-0e7d-46e4-84e4-3e2d691c8cde", "refuuid": "0535f3c0-ab23-411b-be8a-1888e43b01f7", "name": "Oxybutynin", "unii": "K9P6MC7092", "linking_id": "K9P6MC7092", "ref_pname": "Oxybutynin" } }, { "uuid": "952c7426-97ad-4bad-979e-4314c7b111c4", "type": "INHIBITOR->TARGET", "related_substance": { "uuid": "81a622eb-e116-40bb-96c1-e9809ea47364", "refuuid": "0701192a-fd05-4913-83fc-94bd2bc07905", "name": "UMECLIDINIUM", "unii": "GE2T1418SV", "linking_id": "GE2T1418SV", "ref_pname": "UMECLIDINIUM" } }, { "uuid": "71fc623f-a34a-457d-9f80-632b1d39fcdc", "amount": { "uuid": "8bddf761-223c-4ed7-9b56-630f0d696635", "average": 3.72, "high": 4.58, "low": 2.86, "units": "NANOMOLAR" }, "qualification": "Ki", "type": "INHIBITOR->TARGET", "references": [ "1c2b821e-456a-4fad-a955-56b85244b860" ], "related_substance": { "uuid": "2bdc5327-5e2b-45ac-8cb2-fd3a64587f5e", "refuuid": "0285b104-bf9b-4ed0-83b6-d4b840416c5a", "name": "GLYCOPYRROLATE", "unii": "V92SO9WP2I", "linking_id": "V92SO9WP2I", "ref_pname": "GLYCOPYRROLATE" } }, { "uuid": "fd6c3158-d95f-444c-b0c2-66a34c241bcb", "amount": { "uuid": "a1a27093-49fb-45c9-b5e7-9c0f9622eb66", "average": 200, "units": "NANOMOLAR" }, "qualification": "Ki", "type": "WEAK INHIBITOR->TARGET", "references": [ "2f9a66df-6599-4f72-8510-580a5e236f78" ], "related_substance": { "uuid": "90e745b0-d5f8-4505-9f71-5cc84695d073", "refuuid": "36dc506a-1b47-431a-bec5-7673b9338e68", "name": "SOLIFENACIN", "unii": "A8910SQJ1U", "linking_id": "A8910SQJ1U", "ref_pname": "SOLIFENACIN" } }, { "uuid": "8f6b464b-3fce-446d-b625-779e76a69d6f", "amount": { "uuid": "aac2edea-7a1d-475d-9f84-eb7b8036f2e0", "average": 1000, "low": 1000, "units": "NANOMOLAR" }, "qualification": "Ki", "type": "NON-INHIBITOR->OFF TARGET", "interaction_type": "NON-INHIBITOR", "references": [ "9f14f4f4-585f-424b-9016-62683e8613fb" ], "related_substance": { "uuid": "7cdfd316-0ce7-43a8-8dd3-f94ec00a2a12", "refuuid": "d8f372eb-a89e-47ec-a957-bcdb1111df0b", "name": "PALIPERIDONE", "unii": "838F01T721", "linking_id": "838F01T721", "ref_pname": "PALIPERIDONE" } }, { "uuid": "3a692fd2-11d5-40dd-82ad-8f6795044de5", "amount": { "uuid": "47281c8d-aa98-4153-ae11-89eaf65cc1e4", "type": "RELATIVE BINDING AFFINITY", "low": 10000, "units": "NANOMOLAR" }, "qualification": "Ki", "type": "NON-INHIBITOR->OFF TARGET", "references": [ "e6e2a6f7-6bf6-490a-b680-bd62c57b1f01" ], "related_substance": { "uuid": "16826d11-b076-465a-8040-3433b6432f6e", "refuuid": "95270949-f3d1-440d-8635-faa62495c858", "name": "RISPERIDONE", "unii": "L6UH7ZF8HC", "linking_id": "L6UH7ZF8HC", "ref_pname": "RISPERIDONE" } }, { "uuid": "a1e84b9b-1b65-4039-8dfa-65c7dc98e1a7", "amount": { "uuid": "f30153e0-0d09-4e26-93a7-09203ba790e3", "average": 0.1, "units": "NANOMOLAR" }, "qualification": "Ki", "type": "ANTAGONIST->TARGET", "references": [ "b3d374bc-19f8-479d-9a90-52f620afb248" ], "related_substance": { "uuid": "60efe111-4198-48d5-8e65-3d19526c8f1e", "refuuid": "434aa978-93b6-44fb-91e3-0a8b1f0cded7", "name": "ACLIDINIUM", "unii": "K17VY42F6C", "linking_id": "K17VY42F6C", "ref_pname": "ACLIDINIUM" } }, { "uuid": "9d5d74ab-2cba-49a9-9d09-fa8f949c514f", "amount": { "uuid": "f25c67be-5407-47a4-a6a2-d3b4adee309b" }, "type": "INHIBITOR->TARGET", "references": [ "7c4bfc5b-0551-4c1a-a4d4-1cf7761a30e8" ], "related_substance": { "uuid": "deb7cfb0-f362-4d0b-afbd-15933a4b74a4", "refuuid": "d4728d8f-d354-4bd6-916c-a0d1a830048f", "name": "BATEFENTEROL", "unii": "1IAT42T80T", "linking_id": "1IAT42T80T", "ref_pname": "BATEFENTEROL", "substance_class": "reference" } }, { "uuid": "53031f8d-0ba9-4421-8d25-5d92497020fe", "amount": { "uuid": "e1025d1c-3c73-49e8-b634-2b5d1d9ec708" }, "comments": "methoctramine is a selective muscarinic M2 receptor antagonist", "type": "INHIBITOR->TARGET", "references": [ "818010ef-b637-4f4c-83ad-868891abf16f" ], "related_substance": { "uuid": "c312676f-05d8-4a87-855a-e95fe050544e", "refuuid": "c6368687-87ea-4776-b6cf-3dfa08585dfe", "name": "METHOCTRAMINE", "unii": "RLO2T99XT3", "linking_id": "RLO2T99XT3", "ref_pname": "METHOCTRAMINE", "substance_class": "reference" } }, { "uuid": "09ac17b8-6ca1-4a6b-8e91-6e27a81bb90e", "amount": { "uuid": "7429b373-61b8-44e2-8342-6d76f9ef0960" }, "type": "AGONIST->TARGET", "references": [ "c56488f3-afe9-4ae6-8cc7-c64642b5ff4d" ], "related_substance": { "uuid": "02b3a804-0040-4a62-91ec-75841ab2960c", "refuuid": "5d59bc55-62f0-4249-9c0c-4c0e42a43cf8", "name": "METHACHOLINE", "unii": "03V657ZD3V", "linking_id": "03V657ZD3V", "ref_pname": "METHACHOLINE", "substance_class": "reference" } }, { "uuid": "415fba00-e933-4b88-8f53-d4810fea428c", "amount": { "uuid": "b69df074-be58-411e-aa3e-7c47dc50bb9a" }, "type": "PARTIAL AGONIST->TARGET", "references": [ "0a395874-c1e6-43f0-89b9-7330b36bf148" ], "related_substance": { "uuid": "f53853f6-39ba-486b-996a-ceca12c7907d", "refuuid": "390f7e05-d9ee-4c90-aaaf-b38ada5b4e58", "name": "TALSACLIDINE", "unii": "1O8VSL798T", "linking_id": "1O8VSL798T", "ref_pname": "TALSACLIDINE", "substance_class": "reference" } }, { "uuid": "a8de679e-3b11-43c0-aa78-62335a56ee01", "amount": { "uuid": "678f7c53-684c-43f6-9802-5516d488b77d" }, "type": "INHIBITOR->TARGET", "references": [ "747f3aed-b004-4b32-b209-34bb8768c98e" ], "related_substance": { "uuid": "eb255f73-ce79-4bfb-9df9-118379def578", "refuuid": "6c05b8b6-9a04-4d3d-9d24-10be4276d4b2", "name": "ALVAMELINE", "unii": "4XFD7B36M6", "linking_id": "4XFD7B36M6", "ref_pname": "ALVAMELINE", "substance_class": "reference" } }, { "uuid": "4572f2b5-6c86-4d6a-a7bc-77decddef150", "amount": { "uuid": "c3b7f3be-dd01-41ea-8629-62724473ac3b", "average": 4.6, "units": "NANOMOLAR" }, "qualification": "Kd", "type": "RADIOLIGAND->TARGET", "references": [ "fe9a83c2-c91b-485e-af5f-d80a7c6491ff" ], "related_substance": { "uuid": "d475c11f-7f3f-417b-b7d3-49c81115f8d9", "refuuid": "d68a46d2-8f2f-4790-b0b5-b0d5bd64aacf", "name": "AFDX-384 H-3", "unii": "AC2L92BZ4Y", "linking_id": "AC2L92BZ4Y", "ref_pname": "AFDX-384 H-3", "substance_class": "reference" } }, { "uuid": "74d65cdf-90f8-4a78-90c9-dea5c5dbbbd5", "amount": { "uuid": "856b2125-8b08-497b-bc12-1b89f54f7d22", "average": 12, "units": "NANOMOLAR" }, "qualification": "IC50", "type": "INHIBITOR->TARGET", "interaction_type": "BINDING", "references": [ "797bdfd8-76d6-4764-be48-df6df6411d1b" ], "related_substance": { "uuid": "ce187701-1dee-4bd2-a47e-439235ed2212", "refuuid": "bc6e8b53-086f-4e9f-82be-682647e78883", "name": "4-DAMP cation", "unii": "T2C393VHB9", "linking_id": "T2C393VHB9", "ref_pname": "4-DAMP cation", "substance_class": "reference" } }, { "uuid": "23d5e52d-41c4-45d0-855d-4442052138bb", "amount": { "uuid": "d1a855cc-b07c-4365-a8f8-67d2032de15b", "average": 32, "units": "NANOMOLAR" }, "qualification": "IC50", "type": "INHIBITOR->TARGET", "references": [ "dc6ae97f-73cf-4a58-ada8-1573f925ab5f" ], "related_substance": { "uuid": "8353dce8-dfdf-470f-a6da-b0660f58865c", "refuuid": "f23368bb-a6e5-466c-9f30-6f1a4f38ff51", "name": "METHOCTRAMINE FREE BASE", "unii": "NVJ76B897D", "linking_id": "NVJ76B897D", "ref_pname": "METHOCTRAMINE FREE BASE", "substance_class": "reference" } }, { "uuid": "3617b73b-53d9-474d-b8ca-81b35c56b7ad", "amount": { "uuid": "06ee66bc-2be9-4eb8-8358-75bdcfb70afd" }, "type": "AGONIST->TARGET", "references": [ "acb7d578-a157-40ca-a3ea-ed89440b15e0" ], "related_substance": { "uuid": "bc77df8e-f82b-49bd-9c77-791abae1865e", "refuuid": "4bd4dc04-a436-468e-b182-a092daa6b727", "name": "MILAMELINE", "unii": "R9X77R42FN", "linking_id": "R9X77R42FN", "ref_pname": "MILAMELINE", "substance_class": "reference" } }, { "uuid": "3c9562cc-5cea-4126-9b99-9313e73208a1", "amount": { "uuid": "87a18072-95ce-40f6-b614-745bfaad5e5b", "average": 0.55, "units": "MICROMOLAR" }, "qualification": "IC50", "type": "INHIBITOR->OFF-TARGET", "references": [ "01fdec83-2785-479e-86b7-e714da293922" ], "related_substance": { "uuid": "404b496c-1ca9-4a49-8b17-8aa569d2431c", "refuuid": "fa14278f-f91e-403c-a7b3-e028a3ee674b", "name": "Pirenzepine", "unii": "3G0285N20N", "linking_id": "3G0285N20N", "ref_pname": "Pirenzepine", "substance_class": "reference" } }, { "uuid": "6e2ad28c-0f51-4b6f-a64f-a90d8db820e8", "amount": { "uuid": "095d45f0-1b7c-4e40-bee5-f0183db3a4f6" }, "type": "AGONIST->TARGET", "references": [ "0f6a3922-8b1f-4c7d-9448-95b348ec465a" ], "related_substance": { "uuid": "013a3943-cfcf-4a62-b3e7-d5dfe93a05bc", "refuuid": "e7537bc5-8a3a-4f78-93ac-34b8da7fd3bf", "name": "XANOMELINE", "unii": "9ORI6L73CJ", "linking_id": "9ORI6L73CJ", "ref_pname": "XANOMELINE", "substance_class": "reference" } }, { "uuid": "601bf96b-74e0-4aa8-b465-b916044665f1", "amount": { "uuid": "ac654c41-2fdc-4421-829b-e3c4b5623eee", "average": 1, "units": "NANOMOLAR" }, "qualification": "Kd", "type": "INHIBITOR->TARGET", "references": [ "e5a27eb9-9a2c-43f4-a671-b8224ff90f97" ], "related_substance": { "uuid": "c6efedef-862d-491a-8265-c51422f1327c", "refuuid": "d3124cc7-7436-4ac8-8de5-340437dea8db", "name": "AF-DX-384", "unii": "KFR8EX22KX", "linking_id": "KFR8EX22KX", "ref_pname": "AF-DX-384", "substance_class": "reference" } }, { "uuid": "f26d9872-1ca9-480b-85d9-b50f548798ea", "amount": { "uuid": "42cf21cb-f7cc-47ea-8c85-8c5df82e558e" }, "type": "AGONIST->TARGET", "references": [ "128bb5b4-2e26-490c-8642-bd3c0234a1ce" ], "related_substance": { "uuid": "17fb42a2-1363-4814-abcd-6838011d8ac6", "refuuid": "31740658-2033-4e23-a2b8-9be02599583c", "name": "VEDACLIDINE", "unii": "98IW5HAV1N", "linking_id": "98IW5HAV1N", "ref_pname": "VEDACLIDINE", "substance_class": "reference" } }, { "uuid": "3ef6ff3c-33db-42af-9cf8-35c8425a3eb0", "amount": { "uuid": "93f92747-2075-4a98-8e7f-94fe51d408f6" }, "type": "INHIBITOR->TARGET", "references": [ "6e335277-5e11-4126-8ba2-bb76325efce6" ], "related_substance": { "uuid": "fe6f7b85-591f-4c3b-b244-325f6c0abe44", "refuuid": "e5994606-49c2-46c8-8dcb-669b6568a893", "name": "ACOTIAMIDE", "unii": "D42OWK5383", "linking_id": "D42OWK5383", "ref_pname": "ACOTIAMIDE", "substance_class": "reference" } }, { "uuid": "11b4056e-8b1a-4e14-93ea-7f2108091a37", "amount": { "uuid": "f895b8c8-71e6-496f-afc7-04661718e7c3", "average": 47.9, "high": 74.1, "low": 30.9, "units": "NANOMOLAR" }, "qualification": "IC50", "type": "WEAK INHIBITOR->TARGET", "interaction_type": "BINDING", "references": [ "6ee65c81-0846-4f24-95b5-bea04a76263c" ], "related_substance": { "uuid": "f185169c-2bfa-44f1-a6ef-ae8d57a6ca15", "refuuid": "d5e47be6-acea-4ed2-9b6a-6ff65012c6ea", "name": "VELUFENACIN", "unii": "WV3E0S3IQB", "linking_id": "WV3E0S3IQB", "ref_pname": "VELUFENACIN", "substance_class": "reference" } }, { "uuid": "4a66ae01-5ca8-47a7-9e47-a16b2318d50d", "amount": { "uuid": "798d5ad1-4b6d-49ed-bc67-ea5b4784bf4e", "average": 2.2, "units": "NANOMOLAR" }, "qualification": "Ki", "type": "RADIOLIGAND->TARGET", "references": [ "561bd1d1-ba49-4fa7-9a9b-9b75e33aedf5" ], "related_substance": { "uuid": "99d1d142-1ae3-4282-ad7e-e23eaea15179", "refuuid": "143ee232-8bd9-404b-acb6-84bbed7cc7c1", "name": "FP-TZTP F-18", "unii": "9A5LBZ98YY", "linking_id": "9A5LBZ98YY", "ref_pname": "FP-TZTP F-18", "substance_class": "reference" } } ], "names": [ { "uuid": "976d93be-c02b-4f73-b333-0ef11eeafef3", "name": "M2", "stdName": "M2", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "b23c0f7c-d9cb-418b-b324-035d7b986c79" ], "display_name": false }, { "uuid": "227fa5e8-7792-40e1-b43a-7b34e8edf2c5", "name": "MUSCARINIC ACETYLCHOLINE RECEPTOR M2", "stdName": "MUSCARINIC ACETYLCHOLINE RECEPTOR M2", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "78802d03-ca85-4eff-8aa4-99d1d06dc546", "b23c0f7c-d9cb-418b-b324-035d7b986c79" ], "display_name": true }, { "uuid": "374295b5-6cf2-4d2b-aa4e-d9fe476cee79", "name": "Muscarinic M2 receptor", "stdName": "MUSCARINIC M2 RECEPTOR", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "8976942e-e03e-4294-ae47-3a7eb8e968fa" ], "display_name": false }, { "uuid": "11db3dc5-e455-4ac0-b492-d545b382162d", "name": "acetylcholine receptor, muscarinic 2", "stdName": "ACETYLCHOLINE RECEPTOR, MUSCARINIC 2", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "fe9a83c2-c91b-485e-af5f-d80a7c6491ff" ], "display_name": false } ], "protein": { "uuid": "d05214ed-0052-4f59-b831-ea5c45d65be7", "glycosylation": { "uuid": "73320ea2-6c53-480d-90e8-2905fbec9c7c", "glycosylation_type": "HUMAN", "n_glycosylation_sites": [ { "residue_index": 2, "subunit_index": 1 }, { "residue_index": 3, "subunit_index": 1 }, { "residue_index": 6, "subunit_index": 1 }, { "residue_index": 9, "subunit_index": 1 } ] }, "subunits": [ { "uuid": "b589f597-a4b5-4f71-bb50-5a6636d5cb63", "sequence": "MNNSTNSSNNSLALTSPYKTFEVVFIVLVAGSLSLVTIIGNILVMVSIKVNRHLQTVNNYFLFSLACADLIIGVFSMNLYTLYTVIGYWPLGPVVCDLWLALDYVVSNASVMNLLIISFDRYFCVTKPLTYPVKRTTKMAGMMIAAAWVLSFILWAPAILFWQFIVGVRTVEDGECYIQFFSNAAVTFGTAIAAFYLPVIIMTVLYWHISRASKSRIKKDKKEPVANQDPVSPSLVQGRIVKPNNNNMPSSDDGLEHNKIQNGKAPRDPVTENCVQGEEKESSNDSTSVSAVASNMRDDEITQDENTVSTSLGHSKDENSKQTCIRIGTKTPKSDSCTPTNTTVEVVGSSGQNGDEKQNIVARKIVKMTKQPAKKKPPPSREKKVTRTILAILLAFIITWAPYNVMVLINTFCAPCIPNTVWTIGYWLCYINSTINPACYALCNATFKKTFKHLLMCHYKNIGATR", "subunit_index": 1 } ], "references": [ "78802d03-ca85-4eff-8aa4-99d1d06dc546" ], "disulfide_links": [ { "sites": [ { "residue_index": 96, "subunit_index": 1 }, { "residue_index": 176, "subunit_index": 1 } ] }, { "sites": [ { "residue_index": 413, "subunit_index": 1 }, { "residue_index": 416, "subunit_index": 1 } ] } ], "protein_sub_type": "", "sequence_origin": "HUMAN", "sequence_type": "COMPLETE" }, "properties": [ { "uuid": "baec4ef8-b0a0-4d93-9eec-70c2bb3396ea", "name": "MOL_WEIGHT", "type": "amount", "value": { "uuid": "03d6da9b-eeee-48a4-b67b-37ae5b4c7ccc", "units": "DA" }, "defining": false, "property_type": "CHEMICAL" }, { "uuid": "36deaf1e-d4df-4305-84f1-d20637657623", "name": "Molecular Formula", "value": { "uuid": "649b21b8-8770-4351-8d31-fc06f3936349", "type": "ESTIMATED", "non_numeric_value": "C2327H3658N607O686P4S26" }, "defining": false, "property_type": "CHEMICAL" } ], "modifications": { "uuid": "0161ec30-bb16-4c6c-a305-5fb9bba45b20", "structural_modifications": [ { "uuid": "294d79db-7691-4608-a831-4ab01e12fef3", "extent": "COMPLETE", "sites": [ { "residue_index": 232, "subunit_index": 1 } ], "molecular_fragment": { "uuid": "46a97484-7fe4-4ff8-b666-c8a663f56c70", "refuuid": "b6eb2edb-1b4d-46ad-92ad-a43f0f545926", "name": "DEXFOSFOSERINE", "unii": "VI4F0K069V", "linking_id": "VI4F0K069V", "ref_pname": "DEXFOSFOSERINE", "substance_class": "reference" }, "structural_modification_type": "AMINO ACID SUBSTITUTION" }, { "uuid": "209d3e76-64f1-45c3-962d-59525451b387", "extent": "COMPLETE", "sites": [ { "residue_index": 446, "subunit_index": 1 }, { "residue_index": 450, "subunit_index": 1 }, { "residue_index": 465, "subunit_index": 1 } ], "molecular_fragment": { "uuid": "e437e85e-83a9-44c3-9002-66f4a49be3d6", "refuuid": "96bbf36a-d049-4313-9712-8608530faef7", "name": "THREONINE PHOSPHATE", "unii": "3L4WX7B1EI", "linking_id": "3L4WX7B1EI", "ref_pname": "THREONINE PHOSPHATE", "substance_class": "reference" }, "structural_modification_type": "AMINO ACID SUBSTITUTION" } ] } } ] }